OTCPK:BITGF (Sweden)
Â
Business Description
Description
Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. The company has divided its products into the areas of organic chemistry, analytical chemistry, and industrial products. Its product portfolio encompasses biotage extrahera, biotage pressure, gravity rack, cartridge processing stations etc. Its clients include government agencies, academic institutions and the pharmaceutical and food industries.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.55 | |||||
| Equity-to-Asset | 0.69 | |||||
| Debt-to-Equity | 0.16 | |||||
| Debt-to-EBITDA | 0.56 | |||||
| Interest Coverage | 9.76 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 13.1 | |||||
| Beneish M-Score | -2.31 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.2 | |||||
| 3-Year EBITDA Growth Rate | 16.4 | |||||
| 3-Year EPS without NRI Growth Rate | 6.5 | |||||
| 3-Year FCF Growth Rate | 39.6 | |||||
| 3-Year Book Growth Rate | 24.5 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 9-Day RSI | 0.32 | |||||
| 14-Day RSI | 2.37 | |||||
| 6-1 Month Momentum % | -22.57 | |||||
| 12-1 Month Momentum % | -49.89 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.51 | |||||
| Quick Ratio | 1.75 | |||||
| Cash Ratio | 0.97 | |||||
| Days Inventory | 158.74 | |||||
| Days Sales Outstanding | 52.32 | |||||
| Days Payable | 37.37 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.08 | |||||
| Dividend Payout Ratio | 0.43 | |||||
| 3-Year Dividend Growth Rate | 2.3 | |||||
| Forward Dividend Yield % | 1.08 | |||||
| 5-Year Yield-on-Cost % | 1.08 | |||||
| 3-Year Average Share Buyback Ratio | -0.4 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 61.25 | |||||
| Operating Margin % | 21.77 | |||||
| Net Margin % | 15.67 | |||||
| ROE % | 17.08 | |||||
| ROA % | 11.93 | |||||
| ROIC % | 15.66 | |||||
| ROC (Joel Greenblatt) % | 103.88 | |||||
| ROCE % | 20.86 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 53.26 | |||||
| PE Ratio without NRI | 53.26 | |||||
| Shiller PE Ratio | 81.42 | |||||
| Price-to-Owner-Earnings | 57.97 | |||||
| PEG Ratio | 1.94 | |||||
| PS Ratio | 8.36 | |||||
| PB Ratio | 7.96 | |||||
| Price-to-Tangible-Book | 26.82 | |||||
| Price-to-Free-Cash-Flow | 44.72 | |||||
| Price-to-Operating-Cash-Flow | 36.86 | |||||
| EV-to-EBIT | 36.56 | |||||
| EV-to-EBITDA | 28.72 | |||||
| EV-to-Revenue | 8.34 | |||||
| EV-to-FCF | 44.65 | |||||
| Price-to-Projected-FCF | 3.16 | |||||
| Price-to-DCF (Earnings Based) | 1.17 | |||||
| Price-to-DCF (FCF Based) | 1.3 | |||||
| Price-to-Median-PS-Value | 1.37 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.62 | |||||
| Price-to-Graham-Number | 7.97 | |||||
| Price-to-Net-Current-Asset-Value | 42.14 | |||||
| Earnings Yield (Greenblatt) % | 2.74 | |||||
| Forward Rate of Return (Yacktman) % | 21.6 |